🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🌍 APMEN TechTalks: Safety and effectiveness of new tools including #tafenoquine and 7-day high-dose #primaquine? Join our next webinar: 🗓️ 26 May 2025 | 🕐 12:00 PM SGT 🎙️ Experts from 🇦🇺, 🇱🇦 & WHO 🔗 Save your spot here: tiny.cc/APMEN53 #APMEN #Malaria #TechTalks

At #WHA78, MMV joined African nations & partners to call for urgent action on drug-resistant #malaria. Without investment in new medicines & stronger health systems, resistance could reverse decades of progress. We must act—together. 📖 bit.ly/3HhNzOf

At Unitaid's #WHA78 co-hosted side event with Medicines for Malaria Venture (MMV) on climate & infectious diseases, Brazil’s Ministry of Health opened by reminding us: climate change is a chance to build a fairer society—but it requires action, collaboration, and health systems ready to engage.

“The COVID-19 pandemic is fresh in our minds, it reminds us that preparedness isn’t optional, it’s essential,” said Dr. Isturini of Indonesia’s Ministry of Health. Since '23, malaria & other outbreaks have nearly tripled, disrupting communities in North Sumatra. Medicines for Malaria Venture (MMV)

“Climate change threatens the progress we’ve made against malaria,” said Dr. Clément Lazarus of France’s Ministry of Health. He reaffirmed France’s strong support for climate & health efforts, praising partnerships like Unitaid for advancing equitable access to health products.

Minister Ibrahima Sy of Senegal warned of resurgence of malaria due to climate variability. He called for stronger lab capacity, climate-trained health staff, and urgent financing, noting national budgets alone can’t absorb the rising burden of climate-related disease.

Dr. Romanello of the Lancet Countdown highlighted a 167% rise in heat-related deaths since the '90s & a 20% expansion in malaria risk areas. As climate change spreads disease, she stressed the need for data-driven adaptation to protect frontline communities & health systems.

Never underestimate the power of #partnerships to address global health problems. MMV has helped deliver 17 antimalarial medicines, including the first single-dose radical cure for relapsing P. vivax #malaria, co-developed with GSK. Learn more: bit.ly/4j8ZBGY

Our ability to respond and adapt to the threats posed by #ClimateChange will help us build more just, resilient and inclusive societies. Yesterday at #WHA78, MMV & partners convened to discuss the intersection of climate change, infectious diseases and health systems.

Approximately 60% of the 1.5 billion people in #Africa are under 25. Empowering Africa’s youth can create an entire generation of health ambassadors, innovators & change-makers who can have a positive impact on health security, both on the continent & across the world. #AfricaDay

MMV and World Health Organization (WHO) are strengthening our scientific collaboration to better address #malaria drug resistance. Read more about our joint activities and the strategic importance of this collaboration: bit.ly/4kaZzQo

United under the theme #OneWorldforHealth, #WHA78 was an opportunity to strengthen existing partnerships & forge new ones, align actions to address health challenges & discuss issues like drug resistance, climate change & improving healthcare outcomes for the most vulnerable.

Celebrating another important milestone in the fight against #malaria & regional supply security in Africa: The Global Fund has procured over 7 million doses of SPAQ from Kenyan pharmaceutical manufacturer Universal Corporation Limited. Read more: bit.ly/4jjC4n2

What if #malaria drugs could treat mosquitoes before they infect humans? Harvard T.H. Chan School of Public Health researchers have identified 2 compounds provided by MMV that kill Plasmodium falciparum parasites in mosquitoes, blocking forward transmission. Read more: bit.ly/43JDdPZ

MMV & GSK have co-developed the first-ever single-dose radical cure for relapsing P vivax #malaria, which has already been launched in Thailand & Brazil. Read more about how GSK is leveraging key partnerships to help build a malaria-free world: bit.ly/4jbdc0I

Improving health science for women can strengthen health security for all. See why expanding women’s health research will drive innovation, improve health outcomes and boost economic growth: bit.ly/4mHMjV0

📢 Calling all African scientists. Do you have an idea that can help accelerate #malaria drug discovery? MMV’s 8th African call for proposals is now open. The deadline to submit applications is 29 August 2025. Learn more: bit.ly/4dLbSk7

James Tibenderana of Malaria Consortium argues that harnessing behavioural science to address the psychological & social factors influencing decision-making can contribute to the sustained, high-coverage protection necessary for #malaria elimination: bit.ly/4dGAiLk

📬 Are you subscribed to our monthly newsletter? Sign up for a quick and insightful overview of MMV’s activities and a glimpse into the global fight against #malaria 👉 bit.ly/4ki1e6s

.World Health Organization (WHO) calls #climatechange the single biggest health threat facing humanity. What does this mean for #malaria, which is endemic in the low-resource settings that are also the most heavily impacted by climate-related disasters? Find out here: bit.ly/3YAzmmc